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ABSTRACT
Introduction Limited evidence exists on the cost- 
effectiveness of interventions to prevent obesity and 
promote healthy body image in adolescents. The SHINE 
(Supporting Healthy Image, Nutrition and Exercise) study is 
a cluster randomised control trial (cRCT) aiming to deliver 
universal education about healthy nutrition and physical 
activity to adolescents, as well as targeted advice to 
young people with body image concerns who are at risk 
of developing disordered eating behaviours. This paper 
describes the methods for the economic evaluation of the 
SHINE cRCT, to determine whether the intervention is cost- 
effective as an obesity prevention measure.
Methods and analysis A public payer perspective will be 
adopted, with intervention costs collected prospectively. 
Within- trial cost- effectiveness analysis (CEA) and cost- 
utility analysis (CUA) will quantify the incremental costs 
and health gains of the intervention as compared with 
usual practice (ie, teacher- delivered curriculum). CEA will 
present results as cost per body mass index unit saved. 
CUA will present results as cost per quality- adjusted 
life year gained. A modelled CUA will extend the target 
population, time horizon and decision context to provide 
valuable information to policymakers on the potential 
for incremental cost offsets attributable to disease 
prevention arising from intervention. Intervention costs 
and effects will be extrapolated to the population of 
Australian adolescents in Grade 7 of secondary school 
(approximate age 13 years) and modelled over the 
cohort’s lifetime. Modelled CUA results will be presented 
as health- adjusted life years saved and healthcare 
cost- savings of diseases averted. Incremental cost- 
effectiveness ratios will be calculated as the difference in 
costs between the intervention and comparator divided by 
the difference in benefit. Semi- structured interviews with 
key intervention stakeholders will explore the potential 
impact of scalability on cost- effectiveness. These data 
will be thematically analysed to inform sensitivity analysis 
of the base case economic evaluation, such that cost- 
effectiveness evidence is reflective of the potential for 
scalability.
Ethics and dissemination Ethics approval was obtained 
from the Deakin University Human Research Ethics 
Committee (#2017–269) and the Victorian Department of 
Education and Training (#2018_003630). Study findings 
will be disseminated through peer- reviewed academic 
papers and participating schools will receive annual 
reports over the 3 years of data collection.
Trial registration number ACTRN 12618000330246; 
Pre- results.
INTRODUCTION
Overweight and obesity in adolescence is 
a serious public health issue globally, with 
both the mean body mass index (BMI) and 
the prevalence of obesity in adolescents 
increasing worldwide over the last four 
decades.1 In Australia, approximately 30% 
of boys and 24% of girls aged 15 to 17 years 
were classified as overweight or obese in 
2017/2018.2 Diet, physical activity and seden-
tary behaviour are recognised as modifiable 
determinants of obesity at the individual 
level, yet evidence suggests that many adoles-
cents do not regularly engage in healthy 
behaviours to reduce their risk of overweight 
and obesity. For instance, in 2011/2012, less 
Strengths and limitations of this study
 ► This protocol contributes to the limited body of evi-
dence on the cost- effectiveness of interventions that 
prevent obesity and promote healthy body image in 
adolescents.
 ► Data collection for the economic evaluation is 
prospectively planned alongside the randomised 
controlled trial that will assess intervention 
effectiveness.
 ► The cost- effectiveness study design will generate 
important information for decision- makers, provid-
ing evidence of the immediate ‘value- for- money’ of 
the intervention.
 ► A modelled economic evaluation will estimate the 
long- term potential for cost- effectiveness of the in-
tervention as an obesity prevention measure.
 ► Qualitative exploration of the potential impacts of 
the programme delivered at scale on costs, effects 
and cost- effectiveness will provide important infor-
mation on scalability of the intervention.
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than 10% of Australian adolescents aged 12 to 17 years 
met recommended daily physical activity guidelines3 and 
recent evidence suggests that Australian children aged 
14 to 18 years consume relatively high amounts of discre-
tionary food, including cakes, biscuits, fried potatoes and 
sugar- sweetened beverages.4
Overweight and obesity are associated with higher 
healthcare costs and greater health burden within child-
hood and adolescence, including negative psychoso-
cial consequences, lower educational attainment and 
increased risk of sleep apnoea, hypertension, type 2 
diabetes and asthma.1 5–7 Evidence also suggests that over-
weight and obesity in childhood and adolescence tracks 
to adulthood,8 leading to adverse health consequences 
throughout the life course related to chronic diseases 
where excess body weight is a risk factor.9 Adolescence 
has been identified as a period of vulnerability, when 
many disordered eating behaviours and attitudes that 
lead to weight gain emerge.10 The adolescent years intro-
duce greater autonomy over food choice, a decrease in 
breakfast consumption, increased frequency of snacking 
and eating outside the home environment, more dispos-
able income, stronger influence from peers and changes 
in physical activity behaviours.11 Adolescence may there-
fore present a window for intervention to reduce body 
weight and image concerns, and to improve nutrition and 
physical activity behaviours.
The evidence for the effectiveness of obesity prevention 
interventions in adolescents (ie, children aged 13 to 18 
years) is currently limited and relatively inconclusive.12 13 
An important finding from a recent Cochrane review was 
that interventions to prevent childhood obesity do not 
appear to result in adverse effects.13 Evidence suggests 
that internet- delivered interventions can reduce weight 
and shape concerns in adolescents,14 15 however limited 
evidence exists on the cost- effectiveness of such interven-
tions. There is also extremely limited evidence to date on 
the cost- effectiveness of interventions to reduce body weight 
and encourage healthy nutrition and physical activity in 
adolescents.16 Information on the cost- effectiveness of 
interventions is an important element in the decision- 
making process, allowing for more informed resource allo-
cation decisions in environments where there are infinite 
wants and needs for health spending yet finite resources 
in terms of funding allocated to health. Cost- effectiveness 
evidence is often informed by data from controlled 
research environments such as randomised controlled 
trials (RCTs), however, there is also a need to better under-
stand the potential impact of the scale- up of interventions 
on the costs, effects and cost- effectiveness of obesity preven-
tion interventions when delivered in the ‘real world’.16 17 
Qualitative methods for economic evaluation have recently 
been highlighted as promising for better understanding 
of the contextual factors of implementation (eg, organ-
isational, environmental, economic factors) that may be 
relevant to decision- makers.18 These methods have not yet 
been comprehensively applied to economic evaluations of 
interventions conducted in controlled research settings to 
provide valuable information on the impacts of scale- up in 
less controlled environments.
The SHINE (Supporting Healthy Image, Nutrition and 
Exercise) study is a cluster RCT (cRCT), with randomisa-
tion at the school level. SHINE aims to deliver universal 
education about healthy nutrition, physical activity and 
well- being behaviours to adolescents, as well as targeted 
advice to young people who may be experiencing or are 
at risk of developing mental health, weight or body image 
disorders. The intervention replaces the usual Health 
and Physical Education (HPE) curriculum for 8 weeks 
and is a self- directed, online learning programme that is 
modelled on cognitive behavioural therapy (CBT) to effect 
change.19 The intervention aims to improve body image, 
mental health, nutrition and physical activity and to help 
prevent the development or progression of overweight and 
obesity. The aim of this paper is to describe the protocol 
for the economic evaluation of the SHINE cRCT. The 
evaluation will address the research question of whether 
the SHINE intervention is cost- effective for reducing BMI 
and increasing physical activity, as compared with usual 
practice. The economic considerations of future scale- up 
of the intervention will also be explored using qualitative 
methods. Combined, this will provide important infor-
mation on the cost- effectiveness of the intervention and 
its potential for wider implementation across Australian 
secondary schools.
METHODS AND ANALYSIS
Design overview
Within- trial cost- effectiveness analysis (CEA) and cost- 
utility analysis (CUA) will be undertaken alongside the 
SHINE study, quantifying the incremental costs and health 
gains of the intervention as compared with usual practice 
(ie, teacher- delivered curriculum). Decision- analytical 
modelling will then extend the target population, time 
horizon and decision context from the within- trial results, 
to provide valuable information to policymakers on the 
potential for incremental cost offsets attributable to disease 
prevention as a result of the intervention. CEA and CUA 
will be conducted at 36 months using an intention- to- treat 
approach. Cost- effectiveness of the SHINE intervention 
will be determined using the commonly accepted Austra-
lian threshold of $A 50 000 per quality- adjusted life year 
(QALY) gained.20 A qualitative study will also explore the 
economic implications of scale- up on the costs, effects and 
cost- effectiveness of the SHINE intervention should it be 
implemented at scale. Reporting of the economic evalua-
tion will follow the Consolidated Health Economic Eval-
uation Reporting Standards (CHEERS)21 and a CHEERS 
checklist will be completed.
Study population
Trial participants will be Grade 7 students (approximately 
13 years of age) attending 30 secondary schools across 
metropolitan Melbourne and country Victoria, Australia.
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Intervention and comparator
The SHINE intervention will consist of an online 
programme, delivered in weekly sessions of approx-
imately 50 min over eight consecutive weeks during 
scheduled HPE lessons as per the national curriculum.19 
The programme consists of four themes on healthy 
habits—nutrition, physical activity, emotions and body 
(self) image—and each theme has multiple modules 
that can be completed in approximately 5 min. In addi-
tion to the online programme, data will be collected 
via questionnaires at baseline (T1), post- intervention 
(T2), 12 months (T3), 24 months (T4) and 36 months 
(T5)(figure 1). The questionnaires include screening 
measures for depressive symptoms and eating disorder 
symptoms. The measures used are the short form of 
the Center for Epidemiologic Studies – Depression 
Scale (CESD10)22 and the Adolescent version of the 
Eating Disorder Examination- Questionnaire (EDE- 
A).23 Results from these screening measures at baseline 
will identify participants who are experiencing or are 
at- risk of having depression, eating disorders or weight 
issues so that they can receive targeted content in the 
SHINE intervention. The pathways for completion are 
self- directed and content is progressively presented, 
with the targeted content surreptitiously delivered so as 
to avoid potential stigma or embarrassment. Interven-
tion content is based on an effective programme orig-
inally developed for college students in the USA (the 
‘Staying Fit’ programme24 25), and modified as both a 
universal and targeted intervention for adolescents in 
the Australian context. The intervention online content 
is based on CBT and provides goal setting and suggested 
self- help strategies to alter unhelpful or unhealthy ways 
of thinking about common adolescent problems to 
support behaviour change. Class teachers will receive 
a training manual on how to access and support the 
SHINE programme (including a telephone hotline for 
teachers available during intervention implementation 
to troubleshoot any potential technical issues). A website 
comprising of key content from the intervention will 
be available for parents to access during the course of 
the intervention, as these have previously been demon-
strated to improve parental attitudes towards weight and 
shape14 26 and are associated with better outcomes.27 
Booster SHINE sessions will be delivered to students 
during one class period in both Grades 8 and 9, 2 and 
3 years after commencement of the programme. The 
study timeline is given in figure 1.
The comparator for the intervention is defined as 
the waitlist control schools who will receive the usual 
national HPE curriculum.19 Schools will be randomised 
to intervention or waitlist- control arms using concealed 
web- based randomisation. Participation will be facili-
tated by ethics approval for passive consent, enabling all 
students in Grade 7 at participating schools to receive 
either the SHINE intervention or standard teacher- 
delivered curriculum. The only students who will not 
be captured are those with written opt- out/non- consent 
from parents. Student assent will also be collected at 
each assessment.
Figure 1 Timeline for the SHINE- SFA randomised controlled trial. HRQoL,health- related quality of life; SHINE, Supporting 
Healthy Image, Nutrition and Exercise.
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Sample size and missing data
We will recruit a minimum of 30 schools from metropol-
itan and regional Victoria. Assuming a high enrolment 
rate associated with the opt- out consent approach28 we 
expect to enrol an average of 150 seventh- grade chil-
dren per school, that is, a total of 4500 participants 
(approximately 2250 in each group). Considering 20% 
attrition, we aim to collect complete data on 3600 partic-
ipants (1800 per group). This sample size provides 80% 
power of detecting the following effect sizes at 36 months 
(α=0.05 and two- sided tests) after allowing for clustering 
of students in classes with the specified design effect (DE), 
assuming the average number of participating students 
per class will be 20.
Overweight and obesity prevalence
Assuming a 30% prevalence of overweight and obesity in 
the control group at 36 months29 a sample of 3600 students 
allows to detect a 5.8% point reduction in the prevalence 
in the intervention group at 36 months (assuming Intra-
class Correlation Coefficient (ICC)=0.05, DE=1.95) or a 
4.9% point reduction (ICC=0.02, DE=1.38).30
BMI z-score
Assuming a conservative 30% prevalence of overweight 
or obesity at baseline, we would have a sample of 540 
such students in each arm. Assuming a SD of 0.38 for 
BMI z- scores at 36 months in this group (informed by our 
previous study), we would be able to detect a difference 
of 0.05 points on the BMI z- score (assuming ICC=0.05, 
DE=1.95) or 0.04 points (ICC=0.02, DE=1.38).
Outcome measures
Study outcome measures relevant to the economic eval-
uation are presented in table 1. Online questionnaires 
will be used to collect all outcome data except height and 
weight, which will be measured by trained research assis-
tants at baseline, and at 8 weeks and 12, 24 and 36 months 
from baseline.
The primary outcome measure for the within- trial CEA 
will be the change in BMI at 36 months in the interven-
tion group, as compared with the waitlist- control group. 
The secondary outcome measure for within- trial CEA will 
include the time spent in physical activity in the interven-
tion group, as compared with the waitlist- control group 
at 12, 24 and 36 months. CUA will also be undertaken 
using the difference in quality of life in the intervention 
group, as referenced to the waitlist- control group at 12, 
24 and 36 months. Quality of life will be measured using 
the adolescent version of the Assessment of Quality of 
Life 6D (AQoL- 6D), a preference- based multi- attribute 
utility instrument comprised of 20 items from six dimen-
sions (independent living, relationships, mental health, 
coping, pain and senses) with an adolescent- specific 
scoring algorithm.31 The items from the six dimensions 
comprising the adolescent version of the AQoL- 6D will 
be used as the outcome measure for evaluation and utility 
values will be adjusted for the adolescent population 
using the adolescent specific preference weights.31
Resource use and intervention costs
Given the intervention is delivered in the school setting, 
the economic evaluation will be conducted from the 
public payer perspective. The public payer perspective 
was chosen as both education and healthcare are publicly, 
universally provided in Australia. The evaluation will be 
undertaken assuming ‘steady state’ conditions (ie, the 
intervention is assumed to be running at full effectiveness 
and costs associated with the programme’s development 
will not be included into the analyses). Incremental costs 
from resource use associated with implementation of the 
intervention will be identified using pathway analysis. 
The research team will collect resource use data along-
side the trial (up to 36 months post intervention) using a 
standardised tool created in Microsoft Excel and a survey 
of teacher time. Study invoices, receipts and published 
values will be used for costing, with all costs measured 
in 2021 Australian dollars. Costs will be reported as total 
cost of the intervention, as well as mean cost per partici-
pant. Where appropriate, costs and consequences will be 
discounted at the commonly accepted 3% discount rate.32 
Table 2 provides a summary of the resource use and inter-
vention costs to be collected alongside the SHINE cRCT.
Within-trial cost-effectiveness and cost-utility analyses
The within- trial CEA and CUA reference year will be 2021 
and will include total costs and effects that accumulate 
during the intervention period (up to 36 months from 
baseline). Results will be presented as the cost per BMI 
unit saved, cost per extra minute of physical activity 
gained and the cost per QALY gained. Incremental cost- 
effectiveness ratios (ICERs) will be calculated as the 
difference in costs between the intervention and the 
comparator divided by the difference in benefit.
Modelled cost-utility analysis
The modelled CUA will assume that the intervention is 
integrated in national curriculum and will include costs 
accumulated during the intervention implementation 
phase and effects that accumulate over a longer time 
horizon, assumed to be rest- of- life or 100 years of age. 
Table 1 Summary of outcome measures for economic 
evaluation
Study outcome measure Method for data collection
BMI, BMI z- score Objectively measured height 
and weight by trained research 
assistants. BMI z- score estimated 
using the WHO reference standard.
Quality of life Online questionnaire using the 
AQoL- 6D45
Physical activity Online questionnaire using the 
APARQ46
APARQ, adolescent physical activity recall questionnaire; AQoL- 
6D, assessment of quality of life 6D; BMI, body mass index.
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Costs and effects will be extrapolated to reflect inter-
vention delivery to the Australian population of Grade 7 
students in all Government and non- Government schools.
A proportional multi- state, multiple cohort life table 
Markov model developed as part of an obesity priority 
setting study in Australia (the ACE- Obesity Policy model) 
will be updated and used to estimate the obesity and 
physical activity- related health outcomes and healthcare 
cost- savings of the SHINE intervention.33 The reference 
year will be 2018 for the modelled CUA, due to the avail-
ability of epidemiological data to inform the model. The 
model uses the ‘relative risk shift’ method for the calcu-
lation of population impact fractions34 to estimate the 
consequences of a change in BMI or a change in physical 
activity on the incidence of related diseases. The obesity- 
related diseases included in the model are ischaemic 
heart disease, hypertensive heart disease, ischaemic 
stroke, diabetes, colorectal cancer, kidney cancer, breast 
cancer, endometrial cancer and osteoarthritis. Physical 
activity- related diseases include ischaemic heart disease, 
stroke, type 2 diabetes, breast cancer and colon cancer, 
with an adjustment factor to avoid double- counting for 
diseases where both obesity and physical inactivity are 
risk factors.35 Cohort- based modelling will allow for the 
disease- related benefits not present in adolescence to be 
estimated assuming lingering BMI effects. Differences in 
the health- related quality of life between healthy weight 
and obese adolescents will be incorporated using utility 
values derived from the study population using the 
AQoL- 6D Adolescent version.
The change in risk arising from a change in BMI and/
or physical activity will be compared against the counter-
factual scenario, where the distributions of BMI and/or 
physical activity in the 2018 Australian population (ie, the 
reference population) remain unchanged. The model 
will use data from the Australian Health Survey 2017–
20182 and disease epidemiology from the Global Burden 
of Disease study36 (table 3). Healthcare costs will be esti-
mated using data from the Australian Institute of Health 
and Welfare, adjusted to 2018 values using the health 
price index.37 Modelling will be undertaken in Microsoft 
Excel and results will be presented as cost per life year 
saved, cost per health- adjusted life years gained (HALYs 
gained), healthcare cost- savings from diseases averted 
and mean ICER assuming maintenance of intervention 
effect over the cohort’s lifetime. Results will be presented 
on a cost- effectiveness plane, where interventions that are 
both health- promoting and cost- saving are considered 
‘dominant’.
Uncertainty and sensitivity analyses
The Microsoft Excel add- in Ersatz38 will be used to esti-
mate the 95% uncertainty intervals around epidemiolog-
ical probabilities and cost estimates using Monte Carlo 
simulation (2000 runs). Sensitivity analyses will be under-
taken for the modelled CUA by varying key assumptions 
around the sustainability of the intervention effect. Sensi-
tivity analyses will also vary the discount rate to 0% and 
5% as per recommended guidelines.39
Qualitative analysis
Semi- structured interviews will be conducted with key inter-
vention stakeholders to explore the potential for scalability 
of the intervention, and the implications for costs, effects 
and cost- effectiveness of the intervention if delivered at 
scale. Key intervention stakeholders (n=20; defined as 
potential programme providers (eg, education department 
and curriculum authority representatives), programme 
deliverers (eg, teachers and principals) and lead interven-
tion researchers (eg, Chief and Associate Investigators, 
Table 2 Resource use and intervention costs collected alongside the SHINE cRCT
Cost category Costs Collection strategy and source of data
Time costs Costs associated with training teachers on intervention 
delivery. Costs associated with lesson planning. Salary 
on- costs will be included.
Teacher time use survey
Published salary values from Government 
websites47 48
Travel costs Costs associated with travel for training or intervention- 
related purposes.
Project administrative records
Published values from Government websites49
Equipment costs Costs include teacher training materials, printing, and so 
on. Consumables/materials costs.
Project administrative records
Costs are estimated assuming steady- state intervention (ie, excluding intervention development costs).
cRCT, cluster randomised control trial; SHINE, Supporting Healthy Image, Nutrition and Exercise.
Table 3 Input parameters for health impact modelling
Parameters
Data source and 
assumptions
Total population estimates 
(population numbers, mortality 
rates, BMI distribution, PA levels)
Australian Bureau of 
Statistics2 50
Disease epidemiology, disability 
weights
Institute for Health 
Metrics and Evaluation51
Relative risks of PA- related 
diseases by risk categories
Zapata- Diomedi et al 
201652
Relative risks, total years of life 
lived with disability
Institute for Health 
Metrics and Evaluation51
Disease healthcare costs Australian Institute of 
Health and Welfare37
BMI, body mass index; PA, physical activity.
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Project Manager)) will be purposively sampled and invited 
to participate in face- to- face or telephone interviews. The 
interviews will be guided by the Knowledge- To- Action 
framework40 and the Consolidated Framework for Imple-
mentation Research41 and will be recorded and transcribed 
verbatim. Data will be analysed thematically using NVivo 
12 software to assist with data coding, and reported as per 
guidelines.42 Data from the interviews will be summarised 
narratively,43 and will also inform further sensitivity anal-
ysis of the modelled CUA by adjusting the cost and effect 
estimates used to determine cost- effectiveness at scale 
according to qualitative findings.
Approvals and registration
The SHINE RCT has been registered with the Australian 
New Zealand Clinical Trials Registry.
Ethics and dissemination
Ethics approval for the SHINE study has been received from 
the Deakin University Human Research Ethics Committee 
(#2017–269) and the Victorian Department of Education 
and Training (#2018_003630). Data pertaining to the 
economic evaluation of the intervention will be held on 
secure servers at Deakin University, Australia, as per ethics 
requirements. Publications planned using this data include 
a peer- reviewed journal article on the cost- effectiveness of 
the intervention at 36 months and a peer- reviewed journal 
article exploring the potential impact on costs, effects and 
cost- effectiveness of scale- up. Findings will be disseminated 
both within academia, to the participating schools and to 
policymakers. Study findings will be placed on the project 
website (https://www. deakin. edu. au/ cphr/ our- research/ 
epidemiology- unit/ research- projects/ shine) to enable 
viewing by study participants and their parents.
STRENGTHS
Results from the within trial CEA and CUA will be supple-
mented with results from a modelled CUA, examining the 
broader potential for cost- effectiveness of the intervention 
by extrapolating costs and effects to a wider population 
and modelling over a longer time horizon. In addition, 
mixed methods research will explore the potential impact 
on costs, effects and cost- effectiveness should the SHINE 
intervention be scaled up in future. The results from the 
proposed economic evaluation will add to the relatively 
limited evidence base on the ‘value for money’ of obesity 
prevention interventions in adolescents, and will provide 
useful information to decision makers both within the 
health and education sectors on the economic case for 
more widespread implementation of the intervention.
LIMITATIONS
A potential limitation of the study may be missing data 
on teacher time costs and outcome measures. Missing 
data will be handled according to published guidelines44 
and multiple imputation approaches will be used. For 
AQoL- 6D missing data we will impute values within each 
dimension as per developer guidelines. Sensitivity anal-
yses will be used to assess the impact of the handling of 
missing data on study findings. The modelled cost- utility 
analysis will also be subject to several limitations, including 
the assumptions used for extrapolating the outcomes and 
costs from a short- term trial to longer- term healthcare 
cost- savings and health benefits and the published limita-
tions of the ACE- Obesity Policy model.33 Sensitivity anal-
yses will be used to assess the impact of assumptions on 
overall study findings.
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